News
BIO-key (BKYI) Q2 2025 Earnings Call Transcript
As of June 30, 2025, BIO-key had current assets of $4 million, including $2.3 million in cash, up from the year-end current assets of $1.9 million, which included $438,000 of cash. Accounts receivable also increased 37% to $984,000 in June 2025 from $718,000 at year-end 2024. And now, operator, at this time, please prepare for the Q&A session.
F&B per cap trends -- There was a double-digit percentage increase in food and beverage per caps at The Garden during Q4 ...
MCLEAN, VA / ACCESS Newswire / August 11, 2025 / Gladstone Investment Corporation (Nasdaq:GAIN) announces the following event ...
Live Updates Live Coverage Has Ended Guidance is In 5:27 pm Here’s what the company said: “Now turning to guidance for Q3 and ...
1d
Lumentum Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
JP Morgan analyst Samik Chatterjee maintained an Overweight rating and boosted the price target from $100 to $123 on July 17, ...
Strategic Education’s second quarter was met with a negative market response, as revenue growth lagged Wall Street ...
Alico, Inc. ( NASDAQ: ALCO) Q3 2025 Earnings Call August 13, 2025 8:30 AM ET Bradley Heine - Chief Financial Officer & Accounting Officer John E. Kiernan - President, CEO & Director Brandon B. Rogers ...
TipRanks on MSN17h
Legend Biotech’s Earnings Call: Growth and Success
Legend Biotech Corporation (($LEGN)) has held its Q2 earnings call. Read on for the main highlights of the call. Legend Biotech’s Earnings Call ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback